These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 4099879)
21. [Virological aspects of tumor diseases in man]. zur Hausen H Fortschr Med; 1973 Oct; 91(30):1176-80. PubMed ID: 4356497 [No Abstract] [Full Text] [Related]
22. Evidence for an oncogenic potential of the Epstein-Barr virus. Henle W; Henle G Cancer Res; 1973 Jun; 33(6):1419-23. PubMed ID: 4352376 [No Abstract] [Full Text] [Related]
23. The Epstein-Barr Virus and malignancy: molecular evidence. Pagano JS Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():797-805. PubMed ID: 50897 [No Abstract] [Full Text] [Related]
25. High anti-EB virus titer in sera of patients with nasopharyngeal carcinoma: a small-scaled seroepidemiological study. Ito Y; Takahashi T; Kawamura A; Tu SM Gan; 1969 Jun; 60(3):335-40. PubMed ID: 4899471 [No Abstract] [Full Text] [Related]
27. [Immunobiology of Burkitt's lymphoma and human leukemias]. Harlozińska A Postepy Hig Med Dosw; 1974; 28(3):271-91. PubMed ID: 4136196 [No Abstract] [Full Text] [Related]
28. Definition of an antigenic system associated with Burkitt's lymphoma. Oettgen HF; Aoki T; Geering G; Boyse EA; Old LJ Cancer Res; 1967 Dec; 27(12):2532-4. PubMed ID: 4170384 [No Abstract] [Full Text] [Related]
29. Epidemiologic aspects of Epstein-Barr virus (EBV)-associated diseases. Henle W; Henle G Ann N Y Acad Sci; 1980; 354():326-31. PubMed ID: 6261650 [No Abstract] [Full Text] [Related]
30. Epstein-Barr virus and epithelial cells: implications for the otolaryngologist. Clark DR; Young LS; Proops DW J Otolaryngol; 1988 Feb; 17(1):1-3. PubMed ID: 2830415 [TBL] [Abstract][Full Text] [Related]
34. [Problems posed by the immunological properties common to Burkitt's lymphoma and cancer. Means of resolving them]. De-Thé G Ann Inst Pasteur (Paris); 1972 Apr; 122(4):767-88. PubMed ID: 4340546 [No Abstract] [Full Text] [Related]
35. RNA related to that of a murine leukemia virus in Burkitt's tumors and nasopharyngeal carcinomas. Kufe D; Hehlmann R; Spiegelman S Proc Natl Acad Sci U S A; 1973 Jan; 70(1):5-9. PubMed ID: 4346039 [TBL] [Abstract][Full Text] [Related]
36. Seroepidemiological studies on carcinoma of the nasopharynx. Lin TM; Yang CS; Chiou JF; Tu SM; Lin CC; Liu CH; Chen KP; Ito Y; Kawamura A; Hirayama T Cancer Res; 1973 Nov; 33(11):2603-8. PubMed ID: 4355974 [No Abstract] [Full Text] [Related]
38. Antibodies to a new antigen induced by Epstein-Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups. Ida S; Sairenji T; Hinuma Y Gan; 1972 Feb; 63(1):49-55. PubMed ID: 4339712 [No Abstract] [Full Text] [Related]
39. Immuno-gel diffusion studies with the Herpes type virus (HTV) associated with Burkitt's lymphoma. Konn M; Yohn DS; Hinuma Y; Yamaguchi J; Grace JT Cancer; 1969 Apr; 23(4):990-7. PubMed ID: 4975669 [No Abstract] [Full Text] [Related]
40. Epstein-Barr virus-regulation studies on somatic-cell hybrids derived from the fusion of Burkitt's lymphoma and nasopharyngeal carcinoma cells with human or mouse partners. Klein G IARC Sci Publ (1971); 1978; (20):369-76. PubMed ID: 215519 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]